Lloyd Price
SEPTEMBER 2, 2018
A shortage of doctors in countries such as China is also spurring demand for new AI tools to analyze medical images and the race is on to commercialize products that could shake up health care systems around the world. The size of the global medical imaging analytics software market is also expected to jump to $4.3
Digital Health Global
JANUARY 26, 2023
LOUGHBOROUGH, England–(BUSINESS WIRE)– Nemaura Medical, Inc. About Nemaura Medical, Inc. Nemaura Medical Inc. is a medical technology company developing and commercialising non-invasive wearable diagnostic devices. The Company is currently also commercialising sugarBEAT® and proBEAT.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
DECEMBER 27, 2022
A $320 million global industry in 2021 projected to reach $640 million* by 2025, the rising number of cancer cases and the demonstrated benefits of digital pathology are fueling significant demand and market growth in the hospital and pharmaceutical industries,” says Henry Izawa, president and CEO at FUJIFILM Healthcare Americas Corporation.
Lloyd Price
JANUARY 22, 2019
The organisation’s vision is to leverage Australia’s existing strengths in health and medical research, medical technology and healthcare delivery into the creation of a world-leading, national, integrated ecosystem for the development, commercialisation and implementation of evidence-based digital health technologies in Australia.
Lloyd Price
AUGUST 5, 2023
link] Intro to Allurion Allurion is a medical technology company that develops and markets weight loss products. Compute Health believes that the combination of Allurion's technology and its own expertise will allow the company to disrupt the weight loss market.
Healthcare IT News - Telehealth
APRIL 9, 2019
"In the future, patient monitoring data will be combined with concurrent streams from numerous other sensors, as almost every life function will be monitored and its data captured and stored," said said Sowmya Rajagopalan, global director of Frost & Sullivan's Advanced Medical Technologies division.
Healthcare IT Today
JANUARY 5, 2024
By 2025, that figure is expected to reach 36%. Healthcare providers, researchers, pharmaceutical companies, and medical technology specialists will all need to take a phased approach to deploying new technologies. The healthcare sector relies on a wide variety of tools and platforms, and they cannot be replaced wholesale.
Expert insights. Personalized for you.
40 
Let's personalize your content